Sniffing out Solutions in The Nasal Drug Delivery Revolution
The nose to brain pathway can be leveraged to unlock new therapeutic possibilities. Learn about the opportunities of N2B delivery.
Insight
What to Expect from Upperton at CPHI Frankfurt 2025
CPHI Frankfurt is one of the most anticipated events in the pharmaceutical calendar. Upperton is proud to be exhibiting.
The New Rules of CDMO Partnerships: What Biotechs Should Be Looking for Next
Biotech companies today seek long-term development partners who can help to de-risk supply chains, accelerate time-to-market.
The Bright Side of Biologic Stability: A Thermofluor Screen for Rational Buffer Optimisation
Learn about the challenges of stabilising injectable biologics.
Biologics vs Small Molecules: Key Considerations in Drug Development
How the body absorbs, distributes, metabolizes, and excretes a drug – differs significantly between the two modalities.
CDMO Services for Finished Dosage Forms (FDF): Formulation, Development, and Manufacturing
Discover how CDMO services support Finished Dosage Form (FDF) development, from formulation to manufacturing and regulatory compliance.
Product Considerations in Sterile Drug Formulation Development
Discover the critical product decisions in sterile drug formulation development. Learn how planning with your CDMO can streamline your path.
Why Project Management Is the Real Differentiator for CDMOs
Discover why project management is the critical success factor for CDMO collaborations. Explore Upperton’s approach.
Finished Dosage Forms vs. APIs: What’s the Difference in Pharmaceutical Manufacturing?
Explore the key differences between Finished Dosage Forms (FDFs) and APIs in drug development and manufacturing.
Upperton Named in The Sunday Times Best Places To Work 2025 Accreditation
We’re delighted to share that Upperton has officially been accredited as on of the Sunday Time Best Places to Work 2025